These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 22407510

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Multicenter, double-blind, placebo-controlled study of mecamylamine monotherapy for Tourette's disorder.
    Silver AA, Shytle RD, Sheehan KH, Sheehan DV, Ramos A, Sanberg PR.
    J Am Acad Child Adolesc Psychiatry; 2001 Sep; 40(9):1103-10. PubMed ID: 11556635
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A randomized, double-blind, placebo-controlled trial of metoclopramide for the treatment of Tourette's disorder.
    Nicolson R, Craven-Thuss B, Smith J, McKinlay BD, Castellanos FX.
    J Am Acad Child Adolesc Psychiatry; 2005 Jul; 44(7):640-6. PubMed ID: 15968232
    [Abstract] [Full Text] [Related]

  • 7. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.
    Ferini-Strambi L, Aarskog D, Partinen M, Chaudhuri KR, Sohr M, Verri D, Albrecht S.
    Sleep Med; 2008 Dec; 9(8):874-81. PubMed ID: 18952497
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
    Müller-Vahl KR, Schneider U, Koblenz A, Jöbges M, Kolbe H, Daldrup T, Emrich HM.
    Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of pregabalin with pramipexole for restless legs syndrome.
    Allen RP, Chen C, Garcia-Borreguero D, Polo O, DuBrava S, Miceli J, Knapp L, Winkelman JW.
    N Engl J Med; 2014 Feb 13; 370(7):621-31. PubMed ID: 24521108
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourette's syndrome.
    Sverd J, Gadow KD, Paolicelli LM.
    J Am Acad Child Adolesc Psychiatry; 1989 Jul 13; 28(4):574-9; discussion 580-2. PubMed ID: 2768152
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J, Swanson JM, Wigal SB, Kratochvil CJ, Boellner SW, Earl CQ, Jiang J, Greenhill L.
    Pediatrics; 2005 Dec 13; 116(6):e777-84. PubMed ID: 16322134
    [Abstract] [Full Text] [Related]

  • 17. The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies.
    Leentjens AF, Koester J, Fruh B, Shephard DT, Barone P, Houben JJ.
    Clin Ther; 2009 Jan 13; 31(1):89-98. PubMed ID: 19243709
    [Abstract] [Full Text] [Related]

  • 18. Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study.
    Cubo E, Fernández Jaén A, Moreno C, Anaya B, González M, Kompoliti K.
    Clin Ther; 2008 Jan 13; 30(1):182-9. PubMed ID: 18343255
    [Abstract] [Full Text] [Related]

  • 19. A controlled trial of propoxyphene and naltrexone in patients with Tourette's syndrome.
    Kurlan R, Majumdar L, Deeley C, Mudholkar GS, Plumb S, Como PG.
    Ann Neurol; 1991 Jul 13; 30(1):19-23. PubMed ID: 1681781
    [Abstract] [Full Text] [Related]

  • 20. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study.
    Masi G, Gagliano A, Siracusano R, Berloffa S, Calarese T, Ilardo G, Pfanner C, Magazù A, Cedro C.
    J Child Adolesc Psychopharmacol; 2012 Apr 13; 22(2):120-5. PubMed ID: 22375853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.